Back To Rising Leaders Gallery
Israel-born Yossi Pollak is young for a CEO of an emerging company of 180 people. But he is learning fast...
Health care is decentralizing, moving away from the inpatient setting and the hospital, and Sight Diagnostics CEO Yossi Pollak says his AI-based blood test is well placed to accelerate the trend.
Back To Rising Leaders Gallery
Israel-born Yossi Pollak is young for a CEO of an emerging company of 180 people. But he is learning fast...
Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.
Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.